OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Squadron Capital Llc Sells 4,000 Shares of Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) major shareholder Squadron Capital Llc sold 4,000 shares of the company’s stock in a transaction on Monday, August 24th. The shares were sold at an average price of $25.75, for a total transaction of $103,000.00. Following the completion of the transaction, the insider owned 6,897,764 shares of the company’s stock, valued at approximately $177,617,423. The trade was a 0.06% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Squadron Capital Llc also recently made the following trade(s):

• On Wednesday, August 26th, Squadron Capital Llc sold 18,000 shares of OrthoPediatrics stock. The shares were sold at an average price of $24.28, for a total transaction of $437,040.00.
• On Tuesday, August 25th, Squadron Capital Llc sold 16,300 shares of OrthoPediatrics stock. The stock was sold at an average price of $24.74, for a total transaction of $403,262.00.

OrthoPediatrics Price Performance

Shares of KIDS opened at $24.03 on Thursday. The company has a debt-to-equity ratio of 0.28, a current ratio of 4.78 and a quick ratio of 2.17. OrthoPediatrics Corp. has a 1-year low of $14.42 and a 1-year high of $26.74. The stock has a market cap of $627.42 million, a PE ratio of -14.30 and a beta of 0.98. The firm has a fifty day moving average price of $21.23 and a 200 day moving average price of $18.58.

OrthoPediatrics (NASDAQ:KIDS) last posted its earnings results on Tuesday, August 4th. The company reported ($0.26) EPS for the quarter, topping analysts’ consensus estimates of ($0.30) by $0.04. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%.The business had revenue of $70.51 million for the quarter, compared to analysts’ expectations of $68.21 million. As a group, sell-side analysts anticipate that OrthoPediatrics Corp. will post -1.14 EPS for the current year.

Hedge Funds Weigh In On OrthoPediatrics

Large investors have recently bought and sold shares of the company. BlackRock Inc. acquired a new stake in shares of OrthoPediatrics in the 2nd quarter worth $24,347,000. Millennium Management LLC raised its holdings in OrthoPediatrics by 48.0% during the fourth quarter. Millennium Management LLC now owns 1,396,495 shares of the company’s stock worth $24,802,000 after purchasing an additional 452,840 shares in the last quarter. AIGH Capital Management LLC acquired a new stake in OrthoPediatrics in the second quarter valued at about $5,161,000. Nantahala Capital Management LLC acquired a new stake in OrthoPediatrics in the second quarter valued at about $4,636,002,000. Finally, AWM Investment Company Inc. purchased a new stake in OrthoPediatrics in the 2nd quarter valued at approximately $4,537,000. Hedge funds and other institutional investors own 69.05% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently weighed in on KIDS. Piper Sandler reissued an “overweight” rating and issued a $25.00 price objective (up from $22.00) on shares of OrthoPediatrics in a report on Wednesday, August 5th. BTIG Research lifted their price objective on shares of OrthoPediatrics from $24.00 to $29.00 and gave the company a “buy” rating in a research note on Thursday, August 20th. Weiss Ratings upgraded shares of OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 5th. Truist Financial set a $22.00 price target on OrthoPediatrics in a report on Wednesday, August 5th. Finally, Needham & Company LLC boosted their price target on OrthoPediatrics from $30.00 to $35.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Nine research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $26.44.

OrthoPediatrics News Summary

Here are the key news stories impacting OrthoPediatrics this week:

• Positive Sentiment: OrthoPediatrics completed the full U.S. commercial launch of its 3P™ Pediatric Plating Platform® Hip System after more than 350 successful implantations during a limited release. The company said the system addresses pediatric hip trauma and deformities, improves fixation and surgical workflow, and is the first of several planned systems in a broader plating portfolio. The launch provides a potential long-term revenue and market-share opportunity, although the company did not provide specific financial guidance. OrthoPediatrics Announces Full Commercial Launch of 3P Pediatric Plating Platform Hip System
• Neutral Sentiment: Reported short interest was listed as zero shares with a zero-day short-interest ratio. However, the filing data also showed an invalid “NaN” change, making the statistic unreliable and providing little usable insight into potential short-selling pressure.
• Negative Sentiment: Director David R. Pelizzon and major shareholder entities associated with Squadron Capital and Jennifer N. Pritzker reported sales totaling 38,300 shares for approximately $943,302 across August 24–26, at prices ranging from $24.28 to $25.75. The transactions reduced the reported position by only about 0.56%, leaving ownership of roughly 6.86 million shares, so the sales appear relatively small compared with the remaining stake. Nevertheless, repeated insider selling can weigh on sentiment, particularly with KIDS trading near its 52-week high. SEC insider transaction filing

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.